Advertisement

Journal of Genetic Counseling

, Volume 25, Issue 5, pp 1075–1084 | Cite as

Family Communication and Cascade Testing for Fragile X Syndrome

  • Melissa Raspa
  • Anne Edwards
  • Anne C. Wheeler
  • Ellen Bishop
  • Donald B. BaileyJr.
Original Research

Abstract

A total of 679 families who had at least one child with fragile X syndrome (FXS) were recruited from a research registry to participate in a survey examining cascade testing and communication about FXS. Families had a total of 1117 children (804 males, 313 females). Most families (84 %) had tested all of their children. The main reason for not testing, which did not differ by gender or age of the child, was that the child did not show signs of FXS (68 %). Families talked with their children about FXS occasionally (47 %) although 16 % said they do not talk about it. Most families (66 %) had told their children their FXS status, with males and those with the premutation being less likely to be told test results. Of those that did not, 46 % said that they would tell their child when they were old enough to understand, whereas 34 % had either decided they would not tell or were not sure if or when they were going to tell. About a quarter of respondents (28 %) indicated that no extended family members had been tested, with income and communication about FXS being the strongest predictors. Results from this large scale survey provide important data on how families communicate about FXS and reasons testing is or is not sought. This information can be used by genetic counsellors in providing follow-up to families after a FXS diagnosis.

Keywords

Fragile X syndrome Family communication Cascade testing Genetic counseling 

Notes

Acknowledgments

The authors express their grateful appreciation to the hundreds of parents who took the time to participate in this survey. We would also like to thank the National Fragile X Foundation and FRAXA Research Foundation would aided in the initial recruitment for the research registry by posting announcements on their web sites.

Compliance with Ethical Standards

Funding

This study was funded by the Centers for Disease Control and Prevention (CDC), National Center on Birth Defects and Developmental Disabilities (NCBDDD) under Cooperative Agreement U01DD000231 to the Association of University Centers on Disabilities (AUCD), Project RTOI 2010-999-01. The content of this material does not necessarily reflect the views and policies of CDC, NCBDDD, or AUCD. Support for the preparation of the manuscript was provided by RTI International.

Conflict of Interest

Melissa Raspa, Anne Edwards, Ellen Bishop, Anne Wheeler, and Don Bailey declare that they have no conflict of interest.

Research involving human participants and/or animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all patients included in the study.

References

  1. Abrams, L., Cronister, A., Brown, W. T., Tassone, F., Sherman, S. L., Finucane, B., et al. (2012). Newborn, Carrier, and Early Childhood Screening Recommendations for Fragile X. Pediatrics, 130, 1126–1135.CrossRefPubMedGoogle Scholar
  2. Anido, A., Carlson, L. M., & Sherman, S. L. (2007). Attitudes toward Fragile X Mutation Carrier Testing from Women Identified in a General Population Survey. Journal of Genetic Counseling, 16, 97–104.CrossRefPubMedGoogle Scholar
  3. Archibald, A. D., Hickerton, C. L., Jaques, A. M., Wake, S., Cohen, J., & Metcalfe, S. A. (2013). “It's about Having the Choice”: Stakeholder Perceptions of Population-Based Genetic Carrier Screening for Fragile X Syndrome. American Journal of Medical Genetics Part A, 161, 48–58.CrossRefGoogle Scholar
  4. Archibald, A. D., Jaques, A. M., Wake, S., Collins, V. R., Cohen, J., & Metcalfe, S. A. (2009). “It’s Something I Need to Consider”: Decisions about Carrier Screening for Fragile X Syndrome in a Population of Non-Pregnant Women. American Journal of Medical Genetics Part A, 149, 2731–2738.CrossRefGoogle Scholar
  5. Bailey Jr., D. B., Bishop, E., Raspa, M., & Skinner, D. (2011). Caregiver opinions about fragile X population screening. Genetics in Medicine, 14(1), 115–121.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bailey Jr., D. B., Hatton, D. D., & Skinner, M. (1998). Early Developmental Trajectories of Males with Fragile X Syndrome. American Journal on Mental Retardation, 103, 29–39.CrossRefPubMedGoogle Scholar
  7. Bailey Jr, D. B., Lewis, M. A., Harris, S. L., Grant, T., Bann, C., Bishop, E.,... & Therrell Jr, B. L. (2013). Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study. Journal of Genetic Counseling, 22(1), 108–117.Google Scholar
  8. Bailey, D. B., Lewis, M. A., Roche, M., & Powell, C. M. (2014). Family relations in the genomic era: Communicating about intergenerational transmission of risk for disability. Family Relations, 63(1), 85–100.CrossRefGoogle Scholar
  9. Bailey, D. B., Raspa, M., Bishop, E., & Holiday, D. (2009). No change in the age of diagnosis for fragile X syndrome: Findings from a national parent survey. Pediatrics, 124(2), 527–533.CrossRefPubMedGoogle Scholar
  10. Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008a). Co-Occurring Conditions Associated with FMR1 Gene Variations: Findings from a National Parent Survey. American Journal of Medical Genetics (Part A), 146, 2060–2069.CrossRefGoogle Scholar
  11. Bailey, D. B., Skinner, D., Davis, A. M., Whitmarsh, I., & Powell, C. (2008b). Ethical, Legal, and Social Concerns about Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues. Pediatrics, 121, e693–e704.CrossRefPubMedGoogle Scholar
  12. Bailey, D. B., Skinner, D., Hatton, D., & Roberts, J. (2000). Family Experiences and Factors Associated with the Diagnosis of Fragile X Syndrome. Journal of Developmental and Behavioral Pediatrics, 21(5), 315–321.CrossRefPubMedGoogle Scholar
  13. Bailey, D. B., Skinner, D., & Sparkman, K. L. (2003). Discovering fragile X syndrome: family experiences and perceptions. Pediatrics, 111(2), 407–416.CrossRefPubMedGoogle Scholar
  14. Bailey Jr., D. B., Skinner, D., & Warren, S. F. (2005). Newborn Screening for Developmental Disabilities: Reframing Presumptive Benefit. American Journal of Public Health, 95(11), 1889.CrossRefPubMedPubMedCentralGoogle Scholar
  15. Bourgeois, J., Coffey, S., Rivera, S. M., Hessl, D., Gane, L. W., Tassone, F., et al. (2009). Fragile X Premutation Disorders–Expanding the Psychiatric Perspective. The Journal of Clinical Psychiatry, 70, 852–862.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Boyle, L. & Kaufmann, W. E. (2010). The Behavioral Phenotype of FMR1 Mutations. American Journal of Medical Genetics (Part C): Seminars in Medical. Genetics, 154, 469–476.Google Scholar
  17. Daly, M. B., Barsevick, A., Miller, S. M., Buckman, R., Costalas, J., Montgomery, S., et al. (2001). Communicating genetic test results to the family: A six-step, skills-building strategy. Family & Community Health, 24(3), 13–26.CrossRefGoogle Scholar
  18. Downing, C. (2005). Negotiating Responsibility: Case Studies of Reproductive Decision-Making and Prenatal Genetic Testing in Families Facing Huntington Disease. Journal of Genetic Counseling, 14(3), 219–234.CrossRefPubMedGoogle Scholar
  19. Fallat, M. E., Katz, A. L., Mercurio, M. R., Moon, M. R., Okun, A. L., Webb, S. A.,... & Bhambhani, V. (2013). Ethical and policy issues in genetic testing and screening of children. Pediatrics, 131(3), 620–622.Google Scholar
  20. Fanos, J. H., Spangner, K. A., & Musci, T. J. (2006). Attitudes toward prenatal screening and testing for fragile X. Genetics in Medicine, 8(2), 129–133.CrossRefPubMedGoogle Scholar
  21. Finucane, B., Abrams, L., Cronister, A., Archibald, A. D., Bennett, R. L., & McConkie-Rosell, A. (2012). Genetic Counseling and Testing for FMR1 Gene Mutations: Practice Guidelines of the National Society of Genetic Counselors. Journal of Genetic Counseling, 21(6), 752–760.Google Scholar
  22. Forrest, L., Delatycki, M., Curnow, L., Couns, M. G., Skene, L., & Aitken, M. (2012). An audit of clinical service examining the uptake of genetic testing by at-risk family members. Genetics in Medicine, 14(1), 122–128.CrossRefPubMedGoogle Scholar
  23. Forrest, L. E., Delatycki, M. B., Skene, L., & Aitken, M. (2007). Communicating Genetic Information in Families–A Review of Guidelines and Position Papers. European Journal of Human Genetics, 15(6), 612–618.CrossRefPubMedGoogle Scholar
  24. Forrest, K., Simpson, S. A., Wilson, B. J., Van Teijlingen, E. R., McKee, L., Haites, N., et al. (2003). To tell or not to tell: Barriers and facilitators in family communication about genetic risk. Clinical Genetics, 64(4), 317–326.CrossRefPubMedGoogle Scholar
  25. Fu, Y. H., Kuhl, D. P., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S.,... & Caskey, C. T. (1991). Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell, 67(6), 1047–1058.Google Scholar
  26. Gaff, C. L., Clarke, A. J., Atkinson, P., Sivell, S., Elwyn, G., Iredale, R., Thornton, H., Dundon, J., Shaw, C., & Edwards, A. (2007). Process and outcome in communication of genetic information within families: A systematic review. European Journal of Human Genetics, 15, 999–1011.Google Scholar
  27. Hagerman, P. J. & Hagerman, R. J. (2004). Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Mental Retardation and Developmental Disabilities Research Reviews, 10, 25–30.CrossRefPubMedGoogle Scholar
  28. Hatton, D. D., Wheeler, A., Sideris, J., Sullivan, K., Reichardt, A., Roberts, J., et al. (2009). Developmental Trajectories of Young Girls with Fragile X Syndrome. American Journal on Intellectual and Developmental Disabilities, 114, 161–171.CrossRefPubMedGoogle Scholar
  29. Heitz, D., Devys, D., Imbert, G., Kretz, C., & Mandel, J. L. (1992). Inheritance of the Fragile X Syndrome: Size of the Fragile X Premutation Is a Major Determinant of the Transition to Full Mutation. Journal of Medical Genetics, 29, 794–801.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Hersh, J. H. & Saul, R. A. (2011). Health supervision for children with fragile X syndrome. Pediatrics, 127(5), 994–1006.CrossRefPubMedGoogle Scholar
  31. Hill, M. K., Archibald, A. D., Cohen, J., & Metcalfe, S. A. (2010). A Systematic Review of Population Screening for Fragile X Syndrome. Genetics in Medicine, 12, 396–410.CrossRefPubMedGoogle Scholar
  32. Jin, P. & Warren, S. T. (2000). Understanding the molecular basis of fragile X syndrome. Human Molecular Genetics, 9(6), 901–908.CrossRefPubMedGoogle Scholar
  33. Kelly, S. E. (2009). Choosing not to Choose: Reproductive Responses of Parents of Children with Genetic Conditions or Impairments. Sociology of Health & Illness, 31(1), 81–97.CrossRefGoogle Scholar
  34. Keysor, C. S. & Mazzocco, M. M. (2002). A developmental approach to understanding fragile X syndrome in females. Microscopy Research and Technique, 57(3), 179–186.CrossRefPubMedGoogle Scholar
  35. Leehey, M. A., Berry-Kravis, E., Goetz, C. G., Zhang, L., Hall, D. A., Li, L., et al. (2008). FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology, 70(16 Part 2), 1397–1402.CrossRefPubMedGoogle Scholar
  36. McClaren, B. J., Aitken, M., Massie, J., Amor, D., Ukoumunne, O. C., Metcalfe, S. A. (2013). Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: Investigating why most relatives do not have testing. Genetics in Medicine, 15, 533–540.Google Scholar
  37. McConkie-Rosell, A., Del Giorno, J., & Heise, E. M. (2011). Communication of genetic risk information to daughters in families with fragile X syndrome: The parent’s perspective. Journal of Genetic Counseling, 20(1), 58–69.CrossRefPubMedGoogle Scholar
  38. McConkie-Rosell, A., Heise, E. M., & Spiridigliozzi, G. A. (2009). Genetic risk communication: Experiences of adolescent girls and young women from families with fragile X syndrome. Journal of Genetic Counseling, 18(4), 313–325.CrossRefPubMedPubMedCentralGoogle Scholar
  39. Metcalfe, S. A. (2012). Carrier Screening in Preconception Consultation in Primary Care. Journal of Community Genetics, 3, 193–203.CrossRefPubMedGoogle Scholar
  40. Mirrett, P. L., Bailey Jr., D. B., Roberts, J. E., & Hatton, D. D. (2004). Developmental Screening and Detection of Developmental Delays in Infants and Toddlers with Fragile X Syndrome. Journal of Developmental and Behavioral Pediatrics, 25, 21–27.CrossRefPubMedGoogle Scholar
  41. Moeschler, J. B., Shevell, M., Saul, R. A., Chen, E., Freedenberg, D. L., Hamid, R.,... & Tarini, B. A. (2014). Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics, 134(3), e903-e918.Google Scholar
  42. Novas, C. & Rose, N. (2000). Genetic risk and the birth of the somatic individual. Economy and Society, 29(4), 485–513.CrossRefGoogle Scholar
  43. Roberts, J. E., Hatton, D. D., & Bailey, D. B. (2001). Development and Behavior of Male Toddlers with Fragile X Syndrome. Journal of Early Intervention, 24, 207–223.CrossRefGoogle Scholar
  44. Roberts, J. E., Mankowski, J. B., Sideris, J., Goldman, B. D., Hatton, D. D., Mirrett, P. L., et al. (2009). Trajectories and Predictors of the Development of very Young Boys with Fragile X Syndrome. Journal of Pediatric Psychology, 34, 827–836.CrossRefPubMedGoogle Scholar
  45. Ross, L. F., Saal, H. M., David, K. L., Anderson, R. R., & American Academy of Pediatrics (2013). Technical Report: Ethical and Policy Issues in Genetic Testing and Screening of Children. Genetics in Medicine, 15(3), 234–245.CrossRefPubMedGoogle Scholar
  46. Sherman, S. L. (2000). Premature ovarian failure in the fragile X syndrome. American Journal of Medical Genetics, 97(3), 189–194.CrossRefPubMedGoogle Scholar
  47. Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7(8), 584–587.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Skinner, D., Choudhury, S., Sideris, J., Guarda, S., Buansi, A., Roche, M., et al. (2011). Parents' Decisions to Screen Newborns for FMR1 Gene Expansions in a Pilot Research Project. Pediatrics, 127(6), e1455–e1463.CrossRefPubMedPubMedCentralGoogle Scholar
  49. Sorensen, P. L., Gane, L. W., Yarborough, M., Hagerman, R. J., & Tassone, F. (2013). Newborn Screening and Cascade Testing for FMR1 Mutations. American Journal of Medical Genetics Part A, 161(1), 59–69.CrossRefGoogle Scholar
  50. Spector, E.B. & Kronquist, K. (2006). Technical Standards and Guidelines for Fragile X Testing: A Revision to the Disease-Specific Supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College Of Medical Genetics. Retrieved March 13, 2015 from https://www-acmg-net.libproxy.lib.unc.edu/Pages/ACMG_Activities/stds-2002/fx.htm
  51. Sullivan, J. & McConkie-Rosell, A. (2010). Helping parents talk to their children (pp. 227–242). In C. L. Gaff & C. L. Bylund (Eds.), Family communication about genetics: Theory and practice. Oxford: Oxford University Press.Google Scholar
  52. Tassone, F. (2014). Newborn Screening for Fragile X Syndrome. JAMA Neurology, 71(3), 355–359.CrossRefPubMedPubMedCentralGoogle Scholar
  53. van Rijn, M. A., De Vries, B. B., Tibben, A., Van den Ouweland, A. M., Halley, D. J., & Niermeijer, M. F. (1997). DNA testing for fragile X syndrome: implications for parents and family. Journal of Medical Genetics, 34(11), 907–911.CrossRefPubMedPubMedCentralGoogle Scholar
  54. Visootsak, J., Hipp, H., Clark, H., Berry-Kravis, E., Anderson, T., & Laney, D. (2014). Climbing the branches of a family tree: diagnosis of fragile X syndrome. The Journal of Pediatrics, 164, 1292–1295.Google Scholar
  55. Wade, C. H., Wilfond, B. S., & McBride, C. M. (2010). Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literature. Genetics in Medicine, 12(6), 317–326.CrossRefPubMedGoogle Scholar
  56. Wakefield, C. E., Meiser, B., Homewood, J., Peate, M., Kirk, J., Warner, B.,... & Tucker, K. (2007). Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. Journal of Genetic Counseling, 16(3), 325–339.Google Scholar
  57. Wehbe, R. M., Spiridigliozzi, G. A., Heise, E. M., Dawson, D. V., & McConkie-Rosell, A. (2009). When to tell and test for genetic carrier status: Perspectives of adolescents and young adults from fragile X families. American Journal of Medical Genetics Part A, 149(6), 1190–1199.CrossRefGoogle Scholar
  58. Wheeler, A. C. (2011). Early Development in Fragile X Syndrome: Implications for Developmental Screening. Early Development in Neurogenetic Disorders, 40, 75.Google Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2016

Authors and Affiliations

  • Melissa Raspa
    • 1
  • Anne Edwards
    • 1
  • Anne C. Wheeler
    • 1
  • Ellen Bishop
    • 2
  • Donald B. BaileyJr.
    • 1
  1. 1.RTI InternationalNCUSA
  2. 2.RTI International, Koger CenterAtlantaUSA

Personalised recommendations